CHINA PHARMA HOLDINGS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $16.6M | $22.6M | $4.9M |
| FY2022 | $13.5M | $17.8M | $2.0M |
| FY2023 | $9.0M | $16.5M | $1.4M |
| FY2024 | $7.1M | $14.9M | $626.9K |
| FY2025 | $8.3M | $31.0M | $345.1K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $16.6M | $22.6M | $4.9M |
| FY2022 | $13.5M | $17.8M | $2.0M |
| FY2023 | $9.0M | $16.5M | $1.4M |
| FY2024 | $7.1M | $14.9M | $626.9K |
| FY2025 | $8.3M | $31.0M | $345.1K |